BerandaEVGN • NASDAQ
add
Evogene Ltd
Tutup sebelumnya
$1,38
Rentang hari
$1,32 - $1,35
Rentang tahun
$0,95 - $2,87
Kapitalisasi pasar
11,59 jt USD
Volume Rata-Rata
110,27 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 884,00 rb | -3,28% |
Biaya operasional | 3,82 jt | — |
Laba bersih | -4,46 jt | — |
Margin laba bersih | -504,75 | — |
Penghasilan per saham | -0,50 | 52,83% |
EBITDA | -2,78 jt | — |
Tarif pajak efektif | -0,02% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 11,69 jt | -44,08% |
Total aset | 33,93 jt | -17,19% |
Total liabilitas | 21,55 jt | 2,49% |
Total ekuitas | 12,38 jt | — |
Saham yang beredar | 8,71 jt | — |
Harga terhadap nilai buku | -3,37 | — |
Tingkat pengembalian aset | -22,50% | — |
Tingkat pengembalian modal | -51,15% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -4,46 jt | — |
Kas dari operasi | -2,30 jt | — |
Kas dari investasi | -989,00 rb | — |
Kas dari pembiayaan | 4,15 jt | — |
Perubahan kas bersih | 834,00 rb | — |
Arus kas bebas | -12,18 jt | — |
Tentang
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Didirikan
1999
Situs
Karyawan
117
